C Zuo, F Wen, J Li, Y Liu, M Li - Documenta Ophthalmologica, 2009 - Springer Abstract To investigate the changes in the multifo- cal electroretinography
(ERG) after combined intravitreal bevacizumab and photodynamic therapy (PDT) for
polypoidal choroidal vasculopathy (PCV) patients. Thirteen eyes of 13 ... Cited by 1 - Related articles - All 2 versions
JB Gunther, MM Altaweel - Survey of Ophthalmology, 2009 - Elsevier The use of intravitreal bevacizumab (Avastin) has greatly expanded since its
introduction into ophthalmic care 3 years ago. A PubMed search on 1 August 2008
revealed 51 ocular disease processes that have been treated with ... Cited by 3 - Related articles - All 23 versions
M Cho, IA Barbazetto, KB Freund - American Journal of Ophthalmology, 2009 - Elsevier Despite success in the majority of patients enrolled in the MARINA and ANCHOR
trials, there was still a minority of patients who continued to lose vision
despite treatment. In addition, some patients who initially experienced ... Related articles - All 24 versions
C Zuo, F Wen, J Li, Y Liu, S Long, S Huang, M … - Graefe's Archive for Clinical and Experimental … - Springer Abstract Purpose To assess the functional changes of retina in patients affected
by polypoidal choroidal vasculopathy (PCV) after combined intravitreal
bevacizumab and photo- dynamic therapy (PDT) by means of contrast ... Related articles - All 2 versions
M Stur - Spektrum der Augenheilkunde, 2008 - Springer Zusammenfassung. Nach Einführung der intravitrealen Therapie ist es zu einem
deutlichen Rückgang der Anwen- dung der photodynamischen Therapie (PDT) mit
Verteporfin gekommen, weil die Resultate nach PDT schlechter sind als nach ... Related articles